Eastwood Bio-Medical Canada Inc. reported earnings results for the second quarter and six months ended April 30, 2023. For the second quarter, the company reported sales was CAD 0.200203 million compared to CAD 0.242976 million a year ago. Revenue was CAD 0.219651 million compared to CAD 0.265376 million a year ago. Net loss was CAD 0.175832 million compared to CAD 0.066502 million a year ago.
For the six months, sales was CAD 0.478166 million compared to CAD 0.549519 million a year ago. Revenue was CAD 0.551838 million compared to CAD 0.633624 million a year ago. Net loss was CAD 0.245065 million compared to CAD 0.039602 million a year ago.